Drugs
(XML - 5KB)Current Drug Shortages S - Z
The information provided in this section is provided voluntarily by manufacturers. FDA cannot require firms to report the reason for shortage or duration of the shortage or any other information about shortages. FDA appreciates all information provided by manufacturers. We post information about shortages as soon as we receive it from the manufacturers. To report information about shortages or supply issues, manufacturers can send updates to drugshortages@fda.hhs.gov. Healthcare professionals and patients are also encouraged to notify us of shortages at drugshortages@fda.hhs.gov.
*Food and Drug Administration Safety and Innovation Act (FDASIA) of 2012
Secretin Injection (ChiRhoStim) (Initial posting-6/15/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| ChiRhoClin Customer service- 1-877-272-4888 | 16 mcg vial (NDC 67066-005-01) | Current supply is available until January 2013. | Qualifying a new manufacturing site. See the Dear Health Care Provider Letter: Secretin Injection (ChiRhoStim) (PDF -110KB)
| Other | Revised 10/22/2012 |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| American Regent/Luitpold 1-800-645-1706 | 40 mcg/mL elemental selenium | Unavailable | Shortage per Manufacturer: | Other | Revised 10/17/2012 |
Sodium Acetate Injection (Initial Posting Date) - 1/31/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 2 mEq/mL, 100 mL vial (NDC 63323-0032-61) | Back-ordered. Next delivery November 2012 | APP has sodium acetate on back order and expects a release November 2012.
Shortage per Manufacturer: | Demand increase for the drug. | Revised 10/3/2012 |
American Regent, Inc./Luitpold | 2 mEq/mL, 20 mL vial (NDC 00517-2096-25) | Unavailable | Shortage per Manufacturer: Increased Demand American Regent is currently not releasing the 20 mL or 50mL vials. | Discontinuation of the manufacture of the drug. | Reverified 10/17/2012 |
| 2 mEq/mL, 100 mL vial (NDC 00517-2500-25) | Discontinued | ||||
| 4 mEq/mL, 50 mL vial (NDC 00517-5023-25) | Unavailable | ||||
| Hospira Inc. Customer Service 1-877-946-7747 | 2 mEq/mL; 20 mL vial (NDC 0409-7299-73) | Available | Please check with your wholesaler for available inventory. Shortage per Manufacturer:
| Demand increase for the drug. | Revised 10/12/2012 |
| 2 mEq/mL; 50 mL vial (NDC 0409-3299-05) | Available | ||||
| 2 mEq/mL; 100 mL vial (NDC 0409-3299-06) | Next delivery October Estimated recovery: December |
Sodium Bicarbonate Injection (Initial Posting-3/20/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Amphastar Pharmaceuticals Inc. Customer Service: 1-800-423-4136 | 8.4%, 50mL Luer-Jet Prefilled Syringe
NDC 76329-3352-1 (old NDC 0548-3352-00) | Amphastar will regularly release products. | Amphastar is experiencing a product shortage due to an increase in product demand caused by market supply issues. Shortage per Manufacturer: | Demand increase for the drug. | Reverified 10/22/2012 |
APP | 4.2% 2.5 mEq, 5 mL (NDC 63323-0026-05) | Next delivery expected late October. | Please check wholesalers for inventory. Shortage per Manufacturer: | Demand increase for the drug. | Revised 10/18/2012 |
| Hospira, Inc. Customer Service: 1-877-946-7747 | 4%; 5 mL vial (NDC 0409-6609-02) | Available | Please check with your wholesaler for available inventory.
Shortage per Manufacturer: | Demand increase for the drug | Revised 10/22/2012 |
| 0.5 mEq/mL; 10 mL Abboject (NDC 0409-5534-34) | Next delivery October Estimated recovery 1Q 2013 | ||||
| 0.9 mEq/mL; 50 mL Abboject (NDC 0409-4916-34) | Next delivery October Estimated recovery January | ||||
| 1 mEq/mL; 50 mL vial (NDC 0409-6625-02) | Next delivery November Estimated recovery 4Q 2012 | ||||
| 1 mEq/mL; 50 mL Abboject (NDC 0409-6637-34) | Next delivery November/Estimated recovery 1Q 2013 | ||||
| 1 mEq/mL; 10 mL Abboject (NDC 0409-4900-34) | Next delivery October Estimated recovery December |
Sodium Chloride 0.9% (5.8mL and 20mL) (Initial Posting Date) – 5/4/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Lantheus Medical Imaging 1-800-299-3431 | 5.8 mL, pack of 6 vials (NDC 11994-512-05) with Technetium Tc99m Generator | Lantheus has Sodium Chloride 0.9% (5.8mL and 20mL) on back order and cannot estimate a release date. | Commercially available Sodium Chloride has inconsistent inventory availability. Shortage per Manufacturer: | Requirements related to complying with good manufacturing practices | Reverified 10/3/2012 |
| 20 mL, pack of 6 vials (NDC 11994-512-20) with Technetium Tc99m Generator |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 30 mL vials (NDC 63323-0087-30) | Check Wholesalers for Inventory. | APP has all presentations of sodium chloride 23.4% solution for injection on intermittent back order and the company is releasing product as it becomes available. Shortage per Manufacturer:
| Demand increase for the drug. | Reverified 10/3/2012 |
| 100 mL vials (NDC 63323-0088-61) | |||||
| 200 mL vials (NDC 63323-0088-63) | |||||
| American Regent/Luitpold 1-800-645-1706 | 30 mL vials (NDC 00517-2930-25) | Unavailable | American Regent/Luitpold is no longer manufacturing Sodium Chloride Injection 23.4%.. | Discontinuation of the manufacture of the drug. | Reverified 10/17/2012 |
| 100 mL vials (NDC 00517-2900-25) | |||||
| Hospira Inc. Customer Service: 1-877-946-7747 | 4 mEq/mL; 250 mL bottle (NDC 0409-1130-02) | Next delivery 1Q 2013 Expected recovery 1Q 2013 | Shortage per Manufacturer: | Other | Revised 10/12/2012 |
| 4 mEq/mL; 100 mL bottle (NDC 0409-1141-02) | Next delivery 1Q 2013 Expected recovery 1Q 2013 |
Succinylcholine Injection - (Initial posting-8/17/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service 1-877-946-7747 | 20 mg/mL; 10 mL vial NDC 0409-6629-02 | Next delivery October/Estimated recovery 1Q 2013 | Dear Healthcare Professional Letter (PDF - 134KB)
Dear Healthcare Professional Letter (PDF - 69KB) Quelicin Update | Shortage of an active ingredient. | Reverified 10/12/2012 |
| 100 mg/mL; 10 mL vial NDC 0409-6970-10 | Expected availability is TBD | ||||
| Sandoz Inc. Customer Service: 1-800-525-8747 | Anectine, 20 mg/mL, 10 mL vial (NDC 00781-3009-95 | Currently on Backorder. Estimate ongoing shortages into November. | Releasing product on a lot by lot basis. | Demand increase for the drug | Reverified 10/1/2012 |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Akorn: 1-800-932-5676 | 50 mcg/mL, 1 mL ampoule, 10 pack NDC 17478-0050-01 | Available in wholesalers, releasing in October | Quota request filed. (Per manufacturer) Shortage per Manufacturer: | Other | Reverified 10/12/2012 |
50 mcg/mL, 2 mL ampoule, 10 pack NDC 17478-0050-02 | Available in wholesalers, releasing in November | ||||
| 50mcg/ml, 5ml ampule, 10 pack NDC 7478-0050-05 | Readily available | ||||
Hospira, Inc. | Sufentanil 50 mcg/mL 1 mL ampule (NDC 0409-3380-31) | Next delivery 2Q 2013 | Please check with your wholesaler for all available inventory. Shortage per Manufacturer: | Other | Reverified 9/24/2012 |
Sufentanil 50 mcg/mL 1 mL vial (NDC 0409-3382-21) | |||||
Sufentanil 50 mcg/mL 2 mL ampule (NDC 0409-3380-32) | |||||
Sufentanil 50 mcg/mL 2 mL vial (NDC 0409-3382-22) | |||||
Sufentanil 50 mcg/mL 5 mL ampule (NDC 0409-3380-35) | |||||
| Sufentanil 50 mcg/mL 5 mL vial (NDC 0409-3382-25) | |||||
| West-Ward Pharmaceuticals Customer Service: 1-800-631-2174 | 50 mcg/mL, 1 mL ampul | West-Ward is currently experiencing a backorder situation on all presentations. Multiple lots of each code are scheduled for production and anticipated to be available at the end July or beginning of August 2012. | West-Ward has accelerated production. Product will be made available as it is released. Shortage per Manufacturer: Increase in product demand. | Demand increase for the drug. | Revised 7/9/2012 |
50 mcg/mL, 2 mL ampul (NDC 0641-6111-10) | |||||
50 mcg/mL, 5 mL ampul (NDC 0641-6112-10) |
Sulfamethoxazole 80mg/trimethoprim 16mg/ml injection (SMX/TMP)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Teva Pharmaceuticals | 80 mg/16 mg/mL, 5 mL (NDC 00703-9503-03) | Teva is on backorder for the 5mL. The 10mL presentation is available, orders are reviewed prior to distribution. | Requirements related to complying with good manufacturing practices | Reverified 10/18/2012 | |
| 80 mg/16 mg/mL, 10 mL (NDC 00703-9514-03) | |||||
| 80 mg/16 mg/mL, 30 mL (NDC 00703-9526-01 | The 30 mL is on back order and Teva estimates a release date of Jan 2013. | ||||
Telavancin (Vibativ) Injection (updated 1/6/2012)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Astellas Pharma US, Inc. 1-800-727-7003 | PDS 750 mg (NDC 00469-3575-50) | Astellas has no estimated date of availability. | See the Dear Health Care Provider Letter (PDF - 142KB)34 Shortage per Manufacturer:
| Other | 1/6/2012 |
| PDS 250 mg (NDC 00469-3525-30) |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Teva Pharmaceuticals 1-888-838-2872 | 250 mg, 100 count (NDC 00172-2416-60) | Temporarily unavailable | Teva has all tetracycline capsules temporarily unavailable and the company cannot estimate a release date. | Shortage of active ingredient. | Reverified 10/18/2012 |
| 250 mg, 100 count unit dose (NDC 00172-2416-10) | Temporarily unavailable | ||||
| 250 mg, 1000 count (NDC 00172-2416-80) | Temporarily unavailable | ||||
| 500 mg, 100 count (NDC 00172-2407-60) | Temporarily unavailable | ||||
| 500 mg, 100 count unit dose (00172-2407-10) | Temporarily unavailable | ||||
| 500 mg, 1000 count (NDC 00172-2407-80) | Temporarily unavailable | ||||
| Watson Customer Service: (973) 355-8300 | 250 mg, 100 count (NDC 00591-2234-01) | Watson has all tetracycline capsules temporarily unavailable and the company cannot estimate a release date. Shortage per Manufacturer: | Other | Reverified 5/17/2012 | |
| 250 mg, 1000 count (NDC 00591-2234-10) | |||||
| 500 mg, 100 count (NDC 00591-2235-01) | |||||
| 500 mg, 1000 count (NDC 00591-2235-10) |
Thiotepa for Injection (updated 12/2/2011)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Bedford Laboratories Customer Service 1-800-562-4797 | 15 mg/mL vial (NDC 55390-0030-10) | Bedford Laboratories has 15mg available in limited quantities. Once this supply is depleted, the next estimated release dates are unknown. | Availability of products is updated on the Bedford Laboratories website. Shortage per Manufacturer: | Discontinuation of the manufacture of the drug. | Revised 4/10/2012 |
Adienne E-mail: guglielmo.bianchi@adienne.com | Please see the Dear Healthcare Professional Letter (PDF - 68KB) for information about emergency supplies that are now available to help address the shortage. | Adienne, in conjunction with the FDA, is initiating a temporary importation of Thiotepa for injection, to the United States market. | Other | Revised 7/19/2012 |
Thyrogen (thyrotropin alfa) injection 1.1mg/vial (updated 11/22/2011)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Genzyme Corporation 1-800-745-4447 | 1.1 mg vials, kit with 2 vials Thyrogen and 2 vials diluent (NDC 58468-1849-04) | Intermittent shipments of the product have resumed globally. Genzyme continues to expect that Thyrogen supply constraints will occur through 2012. | Shortage per Manufacturer: Temporary Delays | Other | 11/22/2011 |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Forest Pharmaceuticals 1-800-678-1605 | Forest has not yet reported when Thyrolar will be available. | Shortage per Manufacturer: Manufacturing delays | Other |
Ticarcillin disodium/Clavulanic Potassium Injection (Timentin) (Initial posting-8/16/12)
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
GlaxoSmithKline | 3.1 gm/50 mL vial (NDC# 00029-6571- 26) | Out of stock | Batches of the
Shortage per Manufacturer: | Other | Reverified 8/21/2012 |
| 31 gm/100 mL bulk package (NDC# 00029- 6579-21) | Available | ||||
| 3.1 gm ADDVantage vial (NDC# 00029- 6571-40) | Discontinued with some supply still available. |
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Teva Pharmaceuticals 1-800-545-8800 | 250 mg, 100 count (NDC 00093-0154-01) | Available. Teva supply adequate to meet demand. | Reverified 10/18/2012 | ||
| Apotex Corporation Customer Service: 1-(877)-4-Apotex | Ticlopidine Tablets 250 mg, 30 count (NDC 60505-0027-02) | Temporarily unavailable.
Tenatative release revised to Nov-Dec 2012. | Shortage per Manufacturer: This product is unavailable. | Discontinuation of the manufacture of the drug | Reverified 10/12/2012 |
| Ticlopidine Tablets 250 mg, 60 count (NDC 60505-0027-04) | |||||
| Ticlopidine Tablets 250 mg, 500 count (NDC 60505-0027-07) | |||||
Tobramycin Solution for Injection
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Teva Pharmaceuticals | 40 mg/mL, 2 mL vial (NDC 00703-9402-04) | All tobramycin 40 mg/mL solution for injection on long term back order and the company cannot estimate a release date. | Requirements related to complying with good manufacturing practices. | Reverified | |
40 mg/mL, 30 mL vial (NDC 00703-9416-01) | |||||
Pfizer
| 40 mg/mL, 2 mL vial (NDC 00069-0088-02) | The 2mL vial is expected to be available in mid August. | Shortage per Manufacturer: | Other | Reverified |
40 mg/mL, 30 mL vial (NDC 00069-0091-03) | Available | ||||
APP | 10 mg/ml; 2ml vial (NDC 63323-0305-02) | Available | All presentations currently available. Please check wholesalers for inventory. Shortage per Manufacturer: | Demand increase for the drug. | Reverified |
40 mg/mL, 2 mL vial (NDC 63323-0306-02) | Available | ||||
40 mg/mL, 30 mL vial (NDC 63323-0306-30) | Available | ||||
40 mg/mL, 50 mL vial (NDC 63323-0307-51) | Back-ordered. Next delivery expected November 2012 | ||||
40 mg/mL, 2 mL Novaplus vial (NDC 63323-0306-55) | Available | ||||
40 mg/mL, 30 mL Novaplus vial (NDC 63323-0306-56) | Available | ||||
Tobramycin Lyophilized Powder for Injection | Available | ||||
1.2 gram 50 mL vial, preservative-free, 6 count (NDC 63323-0303-51) | Available | ||||
1.2 gram 50 mL Novaplus vial, preservative-free, 6 count (NDC 63323-0303-55) | Available | ||||
Hospira, Inc. | 80 mg/mL in 0.9% NaCl; 100 mL (NDC 0409-3470-23) | Next delivery November
Estimated recovery: 1Q 2013 | Please check with your wholesaler for available inventory. Shortage per Manufacturer:
| Demand increase for the drug. | Revised |
10 mg/mL; 2 mL vial | Next delivery 1 Q 2013
Estimated recovery: 1Q 2013 | ||||
40 mg/mL; 2 mL vial | Next delivery 1 Q 2013
Estimated recovery: 1Q 2013 | ||||
40 mg/mL; 50 mL vial | Next delivery 1 Q 2013
Estimated recovery: 1Q 2013 |
Tromethamine Injection (Initial Posting Date) - 5/2/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| Hospira, Inc. Customer Service: 1-877-946-7747 | 0.3 M; 500 mL bottle (NDC 0409-1593-04) | Next delivery September 2013
Estimated recovery 4Q 2013 | Please check with your wholesaler for available inventory. Shortage per Manufacturer: | Other | Revised 10/23/2012 |
Viaspan Cold Storage Solution 1000 mL Bag (Initial Posting Date) - 4/16/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
Distributed Under the Barr/Duramed Pharmaceuticals Label. Barr & Duramed are Affiliates of Teva Pharmaceuticals USA | 1000 mL bag | Teva supply is adequate to meet demand. | Comments: Contact information for this issue: | Other | Reverified 10/18/2012 |
Vinblastine Sulfate Injection (Initial Posting Date) - 1/31/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| APP 1-888-386-1300 | 1 mg/mL; 10 mL vial (NDC 63323-0278-10) | Available | Check wholesalers for inventory. Shortage per Manufacturer: | Demand increase for the drug. | Reverified 10/3/2012 |
Zinc Injection (Initial Posting Date)- 2/15/2012
| Company | Product | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per New Legislation-FDASIA)* | Date Updated |
|---|---|---|---|---|---|
| American Regent/Luitpold 1-800-645-1706 | 1 mg/mL, 10 mL vial, package of 25 (NDC 00517-6110-25) | Unavailable | American Regent is currently not releasing the 5 mL (concentrate) or the 10 mL vial sizes.
| Discontinuation of the manufacture of the drug. | Reverified 10/17/2012 |
| 5 mg/mL Concentrate, 5 mL vial, package of 25 (NDC 00517-8105-25) | |||||
| Unavailable | |||||
| Hospira, Inc. Customer Service: 1-877-946-7747 | 1 mg/mL, 10 mL vial (NDC 0409-4090-01) | Next delivery October
Estimated recovery 1Q 2013 | Please check with your wholesaler for all available inventory. Shortage per Manufacturer: | Demand increase for the drug. | Revised 10/23/2012 |
